Impaired expression of MHC class II molecules in response to interferon- gamma (IFN-γ) on human thymoma neoplastic epithelial cells

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 01-07

  Inoue, M ^a   Okumura, Meinoshin ^a   Miyoshi, S ^a   Shiono, H ^a   Fukuhara, K ^a   Kadota, Y ^a   Shirakura, R ^a   Matsuda, H ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

HLA DR; MHC; T cell differentiation; Thymic epithelial cell; Thymoma

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMOCYTE; THYMOMA; THYMUS FUNCTION; TUMOR CELL;

EID: 0033012845     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00933.x     Document Type: Article

References (39)

1. Rosai J, Levine GD. Tumors of the Thymus. Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology, 1976.
2. Bernatz PE, Harrison EG, Clagett OT. Thymoma: A clinicopathologic study. J Thorac Cardiovasc Surg 1961; 42:424-44.
3. Salyer WR, Eggleston JC. Thymoma: A clinical and pathological study of 65 cases. Cancer 1976; 37:229-49.
4. Pedraza MA. Thymoma immunological and ultrastructural characterization. Cancer 1977; 39:1455-61.
5. Lauriola L, Piantelli M, Carbone A, Dina MA, Scoppetta C, Musiani P. Subpopulations of lymphocytes in human thymomas. Clin Exp Immunol 1979; 37:502-6.
6. Lauriola L, Maggiano N, Marino M, Carbone A, Piantelli M, Musiani P. Human thymoma: Immunologic characteristics of the lymphocytic component. Cancer 1981; 48:1992-5.
7. Palestro G, Geuna M, Novero D, Godio L, Ciccone G, Azzoni L. Immunophenotype of thymoma-associated lymphoid cell component of T-cell type. A new analytic procedure in keeping with structural heterogeneities. Virchows Arch B, Cell Pathol 1990; 59:297-304.
8. Fujii Y, Hayakawa M, Inada K, Nakahara K. Lymphocytes in thymoma: Association with myasthenia gravis is correlated with increased number of single-positive cells. Eur J Immunol 1990; 20:2355-8.
9. Fujii Y, Hayakawa M, Nakahara K. Thymus cells in myasthenia gravis: A two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma. J Neurol 1992; 239:82-88.
10. Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono H, Miyoshi S, Matsuda H, Shirakura R. Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4 CD8 cells to CD4′ CD8′ cells in vitro. Clin Exp Immunol 1998; 112:419-26.
11. Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono II, Miyoshi S. Matsuda H, Shirakura R. Mature CD4 single positive thymocytes in human thymoma: T cells may differentiate in the thymic epithelial cell tumor. Pathobiol 1997; 65:216-22.
12. Alvarez-Vallina L, Gonzales A, Gambon F, Kreisler M, Diaz-Espada F. Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T cell receptor). J Immunol 1993; 150:8-16.
13. + single positive cells that lack CD3 in the human thymus. Cell Immunol 1993; 151:481-90.
14. - single-positive cells that lack CD69 in epithelial cell tumors of the human thymus. Cell Immunol 1995; 161:181-7.
15. Müller-Hermelink HK, Wilisch A, Schultz A, Marx A. Characterization of the human thymic microenvironment: Lymphoepithelial interaction in normal thymus and thymoma. Arch Histol Cytol 1997; 60:9 28.
16. Sprent J. T lymphocytes and the thymus. In: Paul WE., ed. Fundamental Immunology, 3rd Edn. New York: Raven Press, 1993:75-109.
17. Hugo P, Kappler JW, Murrack PC. Positive selection of TcRαβ thymocytes: Is cortical thymic epithelium an obligatory participant in the presentation of major histocompatibility complex protein? Immunol Rev 1993; 135:133-55.
18. Pink PJ, Bevan MJ. Positive selection of thymocytes. Adv Immunol 1995; 59:99-133.
19. Willcox N, Schluep M, Ritter MA, Schuurman HJ, Newsom-Davis J, Christensson B. Myasthenic and nonmyasthenic thymoma. An expansion or a minor conical epithelial cell subset? Am J Pathol 1987; 127:447-60.
20. Chilosi M, Iannucci A, Fiore-Donati L et al. Myasthenia gravis: Immunohistological heterogencity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown. J Neuroimmunol 1986; 11:191-204.
21. van der Kwast TH, van Vliet E, Cristen E, van Ewijk W, van der Heul RO. An immunohistologic study of the epithelial and lymphoid components of six thymomas. Hum Pathol 1985; 16:1001-8.
22. Savino W, Manganella G, Verley J-M et al. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex. J Clin Invest 1985; 76:1140-6.
23. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48:2485-92.
24. Anderson G, Owen JJT, Moore NC, Jenkinson EJ. Characteristics of an in vitro system of thymocyte positive selection. J Immunol 1994; 153:1915-20.
25. Jenkinson EJ, Anderson G, Owen JJT. Studies on T cell maturation on defined thymic stromal cell populations in vitro. J Exp Med 1992; 176:845-53.
26. + T cells in the thymus. Cell 1993; 73:1041-9.
27. Ashton-Rickardt PG, Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today 1994; 15:362-6.
28. Hogquist KA, Jameson SC, Health WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptiden induce positive selection. Cell 1994; 76:17-27.
29. Jameson SC, Hogquist KA, Bevan MJ. Positive selection of thymocytes, Annu Rev Immunol 1994; 13:93-126.
30. + thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity 1997; 6:401-10.
31. Kirchner T, Tzartos S, Hoppe F, Schalke B, Wekurle H, Müller-Hermelink HK. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigen determinants in tumor-free thymus and thymic epithelial tumors. Am J Pathol 1988; 130:268-80.
32. Laufer TM, DeKoning J, Markowitz TS, Lo D, Glimcher LH. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 1996; 383:81-85.
33. Dekoning J, DiMolfetto I., Reilly C, Wei Q, Havran WL, Lo D. Thymic cortical epithelium in sufficient for the development of mature T cells in relB-deficient mice. J Immunol 1997; 158:2558-66.
34. Crisa L, Cirulli V, Ellisman MH, Ishii JK, Elices MJ, Salomon DR. Cell adhesion and migration are regulated at distinct stages of thymic T cell development: The roles of fibronectin, VLA4, and VLA5. J Exp Med 1996; 184:215-28.
35. He W, Kabelitz D. Cytokines involved in intrathymic T cell development. Int Arch Allergy Immunol 1994: 105:203-10.
36. Watson JD, Morrissey PJ, Namen AE, Conlon PJ, Widmer MB. Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol 1989; 143:1215-22.
37. Bach EA, Aguet M, Schreiber RD. The IFNγ receptor: A paradigm for cytokine receptor signaling. Annu Rev Immunol 1997; 15:563-91.
38. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15:749-95.
39. Zhou H, Su HS, Zhang X, Douhnn J 3rd, Glimcher LH. CIITA-dependent and -independent class II MIIC expression revealed by a dominant negative mutant. J Immunol 1997; 158:4741-9.